Air Force awards $1.8M to VCU startup to advance development of drug treating massive blood loss
Researchers at Virginia Commonwealth University could soon launch a clinical trial to test an intravenous solution that its inventor, a School of Medicine physiologist and surgery professor, says might treat massive blood loss in trauma patients.
Perfusion Medical Inc., a VCU startup working to commercialize the drug called PM-208, has received $1.8 million from the U.S. Air Force that moves the company a step closer to starting clinical trials.
“For a person who is bleeding out, PM-208 may take survival time from minutes to a day or more,” said Martin J. Mangino, Ph.D., a professor of surgery and of physiology and biophysics in the School of Medicine.